These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12052368)

  • 1. The effect of calcitonin and growth hormone on urinary deoxypyridinoline levels in burned patients.
    Akçay MN; Akçay G; Yilmaz I
    Burns; 2002 Jun; 28(4):311-3. PubMed ID: 12052368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of growth hormone on 24-h urinary creatinine levels in burned patients.
    Akçay MN; Akçay G; Solak S; Balik AA; Aylu B
    Burns; 2001 Feb; 27(1):42-5. PubMed ID: 11164664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary free deoxypyridinoline levels during childhood.
    Conti A; Ferrero S; Giambona S; Sartorio A
    J Endocrinol Invest; 1998 May; 21(5):318-22. PubMed ID: 9648054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of calcitonin on bone resorption in hyperthyroidism: a placebo-controlled clinical study.
    Akçay MN; Akçay G; BIlen H
    J Bone Miner Metab; 2004; 22(2):90-3. PubMed ID: 14999518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of bone resorption in early postmenopausal women by intranasal salmon calcitonin in relation to dosage and basal bone turnover.
    Ongphiphadhanakul B; Piaseu N; Chailurkit L; Rajatanavin R
    Calcif Tissue Int; 1998 May; 62(5):379-82. PubMed ID: 9541513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen markers deoxypyridinoline and hydroxylysine glycosides: pediatric reference data and use for growth prediction in growth hormone-deficient children.
    Rauch F; Georg M; Stabrey A; Neu C; Blum WF; Remer T; Manz F; Schoenau E
    Clin Chem; 2002 Feb; 48(2):315-22. PubMed ID: 11805013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat.
    Kapitola J; Zák J; Lacinová Z; Justová V
    Physiol Res; 2000; 49 Suppl 1():S101-6. PubMed ID: 10984078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 12 months rhGH treatment on bone and collagen turnover in children with constitutional growth delay.
    Sartorio A; Conti A; Ferrero S; Saraifoger S; Resnik M; Baroncelli GI
    J Pediatr Endocrinol Metab; 1999; 12(6):833-8. PubMed ID: 10614540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histomorphometric and biochemical characterization of bone following acute severe burns in children.
    Klein GL; Herndon DN; Goodman WG; Langman CB; Phillips WA; Dickson IR; Eastell R; Naylor KE; Maloney NA; Desai M
    Bone; 1995 Nov; 17(5):455-60. PubMed ID: 8579956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
    Coen G; Mantella D; Calabria S; Sardella D; Manni M; Fassino V; D'Anello E; Giustini M; Taggi F
    Am J Nephrol; 2000; 20(4):283-90. PubMed ID: 10970981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
    Ahmed SF; Tucker P; Mushtaq T; Wallace AM; Williams DM; Hughes IA
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults.
    Schlemmer A; Johansen JS; Pedersen SA; Jørgensen JO; Hassager C; Christiansen C
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):471-6. PubMed ID: 1769127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of pyridinium crosslinks in short children treated with growth hormone.
    Branca F; Spagnoli A; Cianfarani S; Spadoni G; Golden MH; Boscherini B; Valtueña S; Robins SP
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):27-34. PubMed ID: 11826867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man.
    Bianda T; Hussain MA; Glatz Y; Bouillon R; Froesch ER; Schmid C
    J Intern Med; 1997 Feb; 241(2):143-50. PubMed ID: 9077371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency.
    Fujimoto S; Kubo T; Tanaka H; Miura M; Seino Y
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1922-8. PubMed ID: 7775642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.